[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
Cordonnier
C
C
Service d'Hématologie, Hôpital Henri Mondor, Créteil, France.
Leverger
G
G
Schlemmer
B
B
Andremont
A
A
Boasson
M
M
Herbrecht
R
R
Kazmierczak
A
A
Marie
J P
JP
Marit
G
G
Miclea
J M
JM
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D000075202:Contraindications; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D005334:Fever / Q000209:etiology*; D005602:France; D006801:Humans; D016867:Immunocompromised Host; D007958:Leukocyte Count; D009181:Mycoses / Q000188:drug therapy; D009503:Neutropenia / Q000097:blood / Q000150:complications*; D012008:Recurrence; D017334:Teicoplanin / Q000627:therapeutic use; D013997:Time Factors; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D017334:Teicoplanin; D014640:Vancomycin
Stratégie antibiotique dans les épisodes fébriles au cours des neutropénies profondes (inférieures à 500 PNN) et prolongées (supérieures ou égales à 7 jours). Recommandations de la Commission d'Evaluation du Collège Français des Hématologistes.